Delcath Systems Inc. (NASDAQ: DCTH) Stock Information | RedChip

Delcath Systems Inc. (NASDAQ: DCTH)


$7.96
-0.0050 ( -0.06% ) 156.4K

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Market Data


Open


$7.96

Previous close


$7.96

Volume


156.4K

Market cap


$221.45M

Day range


$7.92 - $8.06

52 week range


$2.25 - $9.18

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Feb 14, 2024
8-k 8K-related 17 Jan 31, 2024
4 Insider transactions 1 Jan 26, 2024
4 Insider transactions 1 Jan 26, 2024
4 Insider transactions 1 Jan 26, 2024
4 Insider transactions 1 Jan 26, 2024
4 Insider transactions 1 Jan 26, 2024
8-k 8K-related 54 Jan 08, 2024
4 Insider transactions 1 Dec 14, 2023
4 Insider transactions 1 Dec 11, 2023

Latest News